HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhong-Yin Zhang Selected Research

ras Proteins

1/2019Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhong-Yin Zhang Research Topics

Disease

53Neoplasms (Cancer)
04/2024 - 04/2004
15Obesity
11/2022 - 02/2003
11Neoplasm Metastasis (Metastasis)
04/2024 - 01/2006
8Autoimmune Diseases (Autoimmune Disease)
07/2021 - 12/2007
8Carcinogenesis
01/2020 - 02/2007
6Leukemia
09/2023 - 01/2011
5Breast Neoplasms (Breast Cancer)
01/2023 - 06/2006
5Type 2 Diabetes Mellitus (MODY)
10/2015 - 02/2003
5Plague (Bubonic Plague)
08/2010 - 08/2003
4Infections
01/2022 - 11/2013
4Tuberculosis (Tuberculoses)
03/2016 - 03/2013
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2023 - 10/2014
3Ovarian Neoplasms (Ovarian Cancer)
01/2019 - 07/2011
3Fibrosis (Cirrhosis)
01/2018 - 08/2014
3Rheumatoid Arthritis
05/2016 - 12/2007
3Noonan Syndrome (Female Pseudo-Turner Syndrome)
01/2016 - 01/2011
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2015 - 02/2010
2Hematologic Neoplasms (Hematological Malignancy)
04/2024 - 01/2014
2Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 06/2017
2Inflammation (Inflammations)
01/2018 - 01/2017
2Communicable Diseases (Infectious Diseases)
01/2017 - 03/2012
2Neuroinflammatory Diseases
10/2016 - 04/2016
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2016 - 12/2007
2Insulin Resistance
10/2015 - 10/2012
2Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2005 - 11/2003
1Experimental Melanoma
11/2023
1Acute Kidney Injury (Acute Renal Failure)
01/2023
1Adenocarcinoma
01/2023
1Alzheimer Disease (Alzheimer's Disease)
01/2023
1Bites and Stings (Sting)
01/2023
1Cough
01/2023
1Hypertension (High Blood Pressure)
01/2023
1Status Epilepticus (Complex Partial Status Epilepticus)
05/2022
1Glioblastoma (Glioblastoma Multiforme)
01/2022
1Seizures (Absence Seizure)
01/2022
1Brain Neoplasms (Brain Tumor)
01/2022

Drug/Important Bio-Agent (IBA)

40Phosphoric Monoester Hydrolases (Phosphatases)IBA
04/2024 - 02/2003
24Protein Tyrosine PhosphatasesIBA
04/2024 - 08/2003
17Tyrosine (L-Tyrosine)FDA Link
10/2023 - 05/2007
10Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA
01/2023 - 11/2003
8Proteins (Proteins, Gene)FDA Link
04/2024 - 03/2012
86-pyruvoyltetrahydropterin synthase (PTPS)IBA
12/2023 - 06/2008
7LeptinIBA
11/2022 - 02/2003
7Insulin (Novolin)FDA Link
01/2018 - 02/2003
5Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA
11/2023 - 01/2013
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2022 - 06/2008
4Oncogene Proteins (Oncogene Protein)IBA
02/2018 - 07/2011
4Virulence Factors (Pathogenicity Factors)IBA
03/2016 - 08/2003
3PTEN Phosphohydrolase (PTEN Phosphatase)IBA
10/2023 - 07/2008
3Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 07/2011
3Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA
01/2018 - 05/2016
3Glucose (Dextrose)FDA LinkGeneric
01/2015 - 10/2012
3Phosphotransferases (Kinase)IBA
03/2014 - 06/2006
3ErbB Receptors (EGF Receptor)IBA
10/2013 - 01/2006
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2023 - 07/2021
2InterferonsIBA
01/2023 - 01/2017
2Phospholipases A2 (Phospholipase A2)IBA
01/2023 - 07/2011
2Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
01/2023 - 06/2017
2Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
10/2022 - 01/2014
2Insulin ReceptorIBA
01/2018 - 11/2003
2Pro-Opiomelanocortin (Proopiomelanocortin)IBA
01/2018 - 01/2015
2Small Interfering RNA (siRNA)IBA
06/2017 - 11/2013
2CytokinesIBA
01/2016 - 01/2015
2Biomarkers (Surrogate Marker)IBA
01/2014 - 02/2010
1Therapeutic UsesIBA
04/2024
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
09/2023
1AntigensIBA
06/2023
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2023
1coomassie Brilliant BlueIBA
01/2023
1leucylleucine (Leu-Leu)IBA
01/2023
1cloperastineIBA
01/2023
1candesartan cilexetil (Amias)FDA Link
01/2023
14-O-(sulfamoyl)-N-tetradecanoyltyramine (DU 14)IBA
01/2023
1cyclic guanosine monophosphate-adenosine monophosphateIBA
01/2023
1Deubiquitinating EnzymesIBA
01/2023
1ATPases Associated with Diverse Cellular ActivitiesIBA
01/2023
1Valosin Containing ProteinIBA
01/2023
1Lysosomal-Associated Membrane Protein 1IBA
01/2023
1Green Fluorescent ProteinsIBA
01/2023
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2023
1Galectin 3 (LGALS3)IBA
01/2023
1EstersIBA
01/2023
1UbiquitinIBA
01/2023
1Glycerol (Glycerine)FDA LinkGeneric
01/2023
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2023
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2023
1TransferasesIBA
01/2023
1Transcription Factors (Transcription Factor)IBA
01/2023
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
10/2022
1Anticonvulsants (Antiepileptic Drugs)IBA
05/2022
1ArrestinIBA
01/2022
1PQR530IBA
01/2022
1AmylopectinIBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1beta-Arrestin 1IBA
01/2022
1Polysaccharides (Glycans)IBA
01/2022
1RE1-silencing transcription factorIBA
01/2022
14- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA
01/2022

Therapy/Procedure

23Therapeutics
04/2024 - 02/2003
5Immunotherapy
12/2023 - 07/2021